Disease classification of Sars2 covid 19

Miss G made this Freedom of Information request to Medicines and Healthcare Products Regulatory Agency

Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

Medicines and Healthcare Products Regulatory Agency did not have the information requested.

Dear Medicines and Healthcare products Regulatory Agency,

In March 2020 the UK government confirmed that covid 19 was no longer a
HCID.

https://www.gov.uk/guidance/high-consequ...

Can you therefore confirm the following
1) As covid 19 is not a HCID, what type/kind of disease is covid 19 classified as?
2) Is covid 19 a more dangerous disease than HCID's?

We are told covid 19 spreads and transmission occur through contact and airborne, just as HCID's do, therefore, for covid 19 not to be a HCID it must mean that it isn't an acute infectious disease where typically there is
A)a high case-fatality rate
B)may not have effective prophylaxis or treatment
C)often difficult to recognise and detect rapidly
D)ability to spread in the community and within healthcare settings
E)requires an enhanced individual, population and system response to ensure it is managed effectively, efficiently and safely?

3) Which of these identifiers of a HCID does covid 19 not have?, for the government to not class it as a HCID?

4) What are the indicators outwith these and included in the HCID does covid 19 identity, that isn't found in the HCID identifiers?

Yours faithfully,

Miss G Simpson

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 

 

Please note that we may not respond if your query: 

 

• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 

 

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 

 

The UK has left the EU, and the transition period ends on 31 December
2020. Our [1]guidance and information can be accessed here. 

References

Visible links
1. https://www.gov.uk/government/collection...

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Our Ref: FOI 21/082

Dear Miss G Simpson,

RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000

Thank you for your enquiry which we received on 25 January 2021.

I confirm that your request is now being handled under the Freedom of Information Act and you should receive a reply within 20 working days from our date of receipt.

If you need to contact us again about this request, please quote the reference number above.

Kind Regards,


MHRA Customer Service Centre

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf

show quoted sections

Amanda Johnstone left an annotation ()

Dear Miss Simpson

I don't think the MHRA are the appropriate authority to be asking these question. I would suggest the DHSC and PHE.

This FOI request and response may also be of interest:

https://www.whatdotheyknow.com/request/c...

Regards

Amanda

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

FOI 21/082

Miss G Simpson,

Thank you for your email.

We confirm that this is information MHRA does not hold and please note the publication provided is from Public Health England (PHE), and as such any enquiries on this document we advise you contact PHE for information. Please find below contact details.

Email: [email address
  
Telephone: 020 7654 8000  

If you have a query about the information provided, please reply to this email.

If you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Internal review requests should be submitted within two months of the date you receive this response and addressed to: [MHRA request email]

Due to the ongoing Covid-19 situation, we are not able to accept delivery of any documents or correspondence by post or courier to any of our offices

Please remember to quote the reference number above in any future communications.

If you were to remain dissatisfied with the outcome of the internal review, you would have the right to apply directly to the Information Commissioner for a decision. Please bear in mind that the Information Commissioner will not normally review our handling of your request unless you have first contacted us to conduct an internal review. The Information Commissioner can be contacted at:

Information Commissioner’s Office
Wycliffe House
Water Lane
Wilmslow
Cheshire
SK9 5AF

Yours sincerely

MHRA Customer Service Centre

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 0203 080 6000

show quoted sections